Back to Search
Start Over
Remdesivir and its antiviral activity against COVID-19: A systematic review
- Source :
- Clinical Epidemiology and Global Health, Vol 9, Iss , Pp 123-127 (2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- Background: The aim of this study was to summarize the antiviral activities of remdesivir against SARS-CoV-2, the causative agent of COVID-19. Methods: Available publications were systematically explored on some databases and gray literature was examined. Publications were discussed narratively. Results: Remdesivir inhibits SARS-CoV-2 replication, reduces viral load, and exerts protective effects in SARS-CoV-2 infected animals. Remdesivir also reduces the pathological process, alleviates mild symptoms, and improves pulmonary lesions in SARS-CoV-2-infecetd animals. Remdesivir has been used as a compassionate drug for treating COVID-19 patients. Conclusion: Although remdesivir has shown potent antiviral activities, more efficacy assessments are urgently warranted in clinical trials.
Details
- Language :
- English
- ISSN :
- 22133984
- Volume :
- 9
- Issue :
- 123-127
- Database :
- Directory of Open Access Journals
- Journal :
- Clinical Epidemiology and Global Health
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.8a2a01bc6cf74f52b8087c30d50548a1
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.cegh.2020.07.011